Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

ClinicalTrials.gov ID: NCT01756898

Public ClinicalTrials.gov record NCT01756898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 19, 2026, 3:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to gather scientific information about the effectiveness of the study drug, ASB17061 capsules, when compared to placebo in adult subjects with atopic dermatitis.

Study identification

NCT ID
NCT01756898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
370 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2012
Primary completion
Jan 13, 2014
Completion
Jan 13, 2014
Last update posted
Feb 15, 2021

2012 – 2014

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Not listed Birmingham Alabama 35233
Not listed Phoenix Arizona 85018
Not listed Rogers Arkansas 72758
Not listed Encino California 91436
Not listed Fremont California 94538
Not listed San Diego California 92122
Not listed Temecula California 92592
Not listed Denver Colorado 80220
Not listed Miami Florida 33144
Not listed Miami Florida 33175
Not listed Miramar Florida 33027
Not listed Saint Augustine Florida 32086
Not listed South Tampa Florida 33609
Not listed Tampa Florida 33609
Not listed Tampa Florida 33613
Not listed Savannah Georgia 31405
Not listed Boise Idaho 83704
Not listed Overland Park Kansas 66215
Not listed Crowley Louisiana 70526
Not listed Bay City Michigan 48706
Not listed Clinton Township Michigan 48038
Not listed Fort Gratiot Michigan 48059
Not listed Berlin New Jersey 08009
Not listed Verona New Jersey 07044
Not listed Stony Brook New York 11790
Not listed Raleigh North Carolina 27612
Not listed Sylvania Ohio 43560
Not listed Lake Oswego Oregon 97035
Not listed Portland Oregon 97239
Not listed Johnston Rhode Island 02919
Not listed Arlington Texas 76011
Not listed College Station Texas 77845
Not listed Pflugerville Texas 78660
Not listed San Antonio Texas 78229
Not listed Webster Texas 77598
Not listed Draper Utah 84020
Not listed West Jordan Utah 84088
Not listed Henrico Virginia 23233
Not listed Norfolk Virginia 23507
Not listed Spokane Washington 99204-4880

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01756898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 15, 2021 · Synced Sep 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01756898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →